UBS ETFIn order to proceed, you must confirm that you are a qualified or institutional investor based in Finland.

The following information does not constitute distribution.

Please note that this webpage gives qualified investors access to the entire UBS ETF product offering. Therefore, some products on this webpage may NOT be authorized, recognised or registered for distribution neither in Finland, nor in your country or as the case may be nor in any other country. No distribution must be carried out for it. No marketing material must be handed out to clients on any occasion. The presentation of marketing material in client halls is strictly forbidden. Reference to these funds in client mailings must not be made. In case that you don't want or are not allowed to see the full ETF range, please do not proceed. Enter this site as Private Investor.

For marketing and information purposes by UBS.

    For professional clients. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. UBS AG and / or other members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document.

      UBS funds under Luxembourg and Irish law

        Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management

          This document contains statements that constitute “forward-looking statements”, including, but not limited to, statements relating to our future business development. While these forward-looking statements represent our judgments and future expectations concerning the development of our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations.

            Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge from UBS Asset Management, Regeringsgatan 38, S-11153 Stockholm.

              © UBS 2021. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

              Back

              UBS ETF (LU) Solactive China Technology UCITS ETF (hedged to EUR) A-acc

              Net asset value 10.6361EUR

              Last update

              10.06.2021

              ISIN: LU2265794946

              Asset Class: Equities

              Securities lending

              Securities lending is the temporary transfer of securities from the lender (the fund management company) in the name of and for the account of the investment fund to a third party (the borrower). In exchange, the borrower provides the lender with collateral before the delivery of securities, and pays a fee over the period of the loan. All loans within our lending programme are open and rolled daily such that they can be extended or terminated on demand. The fund can thus generate additional income. UBS ETFs engage in securities lending for selected, physically replicated UBS ETFs with the aim of reducing the investor’s net costs. Securities lending with UBS ETFs is always over-collateralised with at least 105% margin across all asset classes. In addition, on-loan balances are capped at 50% of each sub-fund’s AUM. Collateral is held in a custody account that is kept separate from the intermediary’s balance sheet. Daily revaluation at market prices ensures that the value of the collateral provided is always adjusted correctly. To further minimise risks, borrowers are carefully selected. The following types of securities are accepted as collateral (excl. securities of the borrowing counterparty):

              1. Securities issued and/or guaranteed by the governments of the following countries:
                • The following G10 countries: Belgium, the Netherlands, Canada, Sweden, France, Switzerland (SNB Bills), Germany, Japan, UK and USA (including US debt securities and rights issued or guaranteed by the US administration or one of its agencies or instrumentalities.)
                • Only the following OECD countries: Australia, Austria, Denmark, Finland, Luxembourg, New Zealand and Norway.
              2. Equities in the form of world stock indices.

              Collateralisation of the securities lending is continually reviewed and adjusted as necessary. It can therefore be subject to change. For more details about Securities Lending Borrowers please follow the link.

              Collateral 12 month lending summary (as of last month end)

              Min % balance on loan:

              0.00

              Max % balance on loan:1)

              1.47

              Average % balance on loan:2)

              0.48

              Net return to fund in bps:3)

              0.01

              Collateral %:

              0.00

              Source: State Street

              1) The maximum loan value is calculated from the maximum value of the lent securities on a single day within the past 12 months.

              2) The average loan value is calculated by dividing the average percentage value of the securities lent on a daily basis by the fund's daily assets under management (AuM) over the past 12 months.

              3) The fund's annualised net return generated by securities lending is calculated by dividing the fund's securities lending income over a period of 12 months by the fund's average net asset value (NAV) for the same period.

              Of the revenue received by the borrower on the market, 60% is credited to the relevant sub-fund while UBS AG receives 20% to cover the due diligence and the Securities Lending Agent 20% to cover operational costs resulting from the transactions carried out in relation to the securities lending.

              Download all data as XLS File

              Top 10 collateral holdings

              #

              Security

              ISIN

              Country

              Asset Type

              Weight %

              1

              AMAZON.COM INC COMMON STOCK USD 0.01

              US0231351067

              United States

              Equities

              0.07

              2

              XILINX INC COMMON STOCK USD 0.01

              US9839191015

              United States

              Equities

              0.07

              3

              WALMART INC COMMON STOCK USD 0.1

              US9311421039

              United States

              Equities

              0.07

              4

              ALPHABET INC COMMON STOCK USD 0.001

              US02079K3059

              United States

              Equities

              0.07

              5

              BERKSHIRE HATHAWAY INC COMMON STOCK USD 0.0033

              US0846707026

              United States

              Equities

              0.07

              6

              ALEXION PHARMACEUTICALS INC COMMON STOCK USD

              US0153511094

              United States

              Equities

              0.07

              7

              DUKE ENERGY CORP COMMON STOCK USD 0.001

              US26441C2044

              United States

              Equities

              0.05

              8

              MICRON TECHNOLOGY INC COMMON STOCK USD 0.1

              US5951121038

              United States

              Equities

              0.04

              9

              TAKE-TWO INTERACTIVE SOFTWARE INC COMMON STOCK USD

              US8740541094

              United States

              Equities

              0.04

              10

              STARBUCKS CORP COMMON STOCK USD 0.001

              US8552441094

              United States

              Equities

              0.04

              The table above lists the securities that are used as collateral for the securities lent with UBS ETFs. The information presented was obtained from internal and external sources deemed reliable. However, we cannot provide any guarantee of their accuracy and completeness. It should be noted that securities lending is subject to a certain risk where the borrower does not return the borrowed securities according to his/her obligation, and where the value of the collateral provided does not cover the costs of repurchase of the securities. In this case, the borrower shall be liable for any claims arising from the securities lending and not covered by the sale of the securities concerned. Source: State Street, 09.06.2021

              Collateral types and margins

              Collateral Types

              Loan Types

              International Equities

              Government Bonds

              International Equities

              105.00 %

              105.00 %

              US Equities

              105.00 %

              105.00 %

              As per CISA regulation, the value of the collateral must at all times be equal to at least 100% of the market value of the securities lent; as such the requirements applicable to the UBS funds significantly exceed this requirement at all times. Source: State Street, 09.06.2021

              Disclaimer

              For marketing and information purposes by UBS. UBS funds under Luxembourg law. Prospectuses, key investor information (KIID), the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge from UBS Asset Management, Regeringsgatan 38, S-11153 Stockholm. The product described herein aligns to Article 6 of Regulation (EU) 2019/2088. Before investing in a product please read the latest prospectus carefully and thoroughly. The fund documentation is available free of charge in English and, where relevant, in one of the local language(s) where the fund is registered. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. Members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS Asset Management Switzerland AG or a local affiliated company. Source for all data and charts (if not indicated otherwise): UBS Asset Management. More explanations of financial terms can be found at ubs.com/am-glossary. © UBS 2021. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.